Veeva Systems Inc.

“Veeva Systems is a textbook compounding machine — a founder-led vertical SaaS monopoly in life sciences with 44% FCF margins, 16% revenue growth, $7.3B in net cash, and a structurally underpenetrated TAM in R&D and Data Cloud. At ~15.5x EV/FCF near the low-end of its 52-week range, the market is pricing in execution risk around the Vault CRM migration but not the durable, widening competitive moat or the decade-long reinvestment runway ahead. With permanent impairment probability estimated at 8–12% and 80–140% upside to fair value on a 5-year horizon, this is a fat-pitch for long-term investors who can tolerate near-term migration-related volatility.”